EPharmaceuticals

Life Sciences Headlines

Want to receive headlines like these in your inbox? Subscribe to one of our free Life Sciences e-Newsletters

Top Stories

• The Holy Grail of Evidence-Based Medicine

  HealthLeaders Media contributor Mark Hochstetler, MD, says he is probably more optimistic than most healthcare professionals about the value of evidence-based medicine. Hochstetler it is a tool that can be used or misused to achieve certain goals. Misuse doesn't mean the tool should be tossed out—it just needs to be policed, he says.

• Vermont strengthens gift ban

  The Vermont legislature is getting tougher on the pharmaceutical industry by passing a bill that tightens up the state’s existing gift and payment disclosure law.

• No class action status in CA Vioxx lawsuit

  Los Angeles Superior Court Judge Victoria G. Chaney denied class action status to plaintiffs seeking to sue Merck for its withdrawn painkiller Vioxx.

• Editor's Note: Final issue of Device Regulation Alert today

  HCPro is sorry to announce that this is the final issue of Device Regulation Alert. We thank you for being a loyal subscriber.

• Device maker settles allegations it failed to disclose payments to physicians

  Medical device maker Synthes, Inc., based in West Chester, PA, entered into a settlement agreement with the New Jersey Attorney General (AG) to resolve allegations the company failed to disclose financial conflicts-of-interest among doctors who conducted clinical testing on its products, according to the AG.

• Disetronic Medical Systems recalls insulin pumps

  Disetronic Medical Systems issued a recall for its ACCU-CHEK Spirit insulin pumps with serial numbers from SN02119552 through SN10006093 because the “up” and “down” buttons are potentially defective, according to a company release.

More Life Sciences Headlines »